Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Current Leases (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Current Leases for 7 consecutive years, with $14.4 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 6.64% to $14.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.4 million through Dec 2025, up 6.64% year-over-year, with the annual reading at $14.4 million for FY2025, 6.64% up from the prior year.
  • Current Leases for Q4 2025 was $14.4 million at Beam Therapeutics, up from $12.7 million in the prior quarter.
  • The five-year high for Current Leases was $14.4 million in Q4 2025, with the low at $2.1 million in Q1 2021.
  • Average Current Leases over 5 years is $9.5 million, with a median of $11.7 million recorded in 2023.
  • The sharpest move saw Current Leases tumbled 65.92% in 2022, then soared 440.77% in 2023.
  • Over 5 years, Current Leases stood at $2.3 million in 2021, then soared by 353.87% to $10.4 million in 2022, then rose by 23.1% to $12.8 million in 2023, then rose by 5.41% to $13.5 million in 2024, then increased by 6.64% to $14.4 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $14.4 million, $12.7 million, and $12.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.